We with our family andf-riends a
very healthy, happy culdprosperous New Year.

GALE SHAFKIND & FAMILY

93e.o wi.oheJ lop a
happy, healthy
"Otew. <Year.

ter a
'BeAt
Happy, healthy
Oleto Wear.

DAVID & SHARON BERGMAN

MARCY, DOUG, CARLY,
ARI & YOGI

We hour famify and friends a
very healthy, happy atuf prosperous New Teat

We with our family andfriends a
very healthy, happy andprosperous New Year.

MELANIE & AARON WALLIS

DANA, JOEL & MADDI ISHBIA

A Very Happy and
Healthy New Year
to All Our
Friends and Family.

THE FEALKS

HILLARD & JOANNE
GARY, SHARRY & MATTHEW
JOEL & STACI

We wish . our family and friends a
very healthy, happy and prosperous New Year.

We wish ourfamgy anal friends a
very healthy, happy and prosperous New Tear.

TOBI & JENOE ROTH

LIMMOON=IMI=M ■■

nalla

12.1-011 111.5 111t1r2

MAy ThE NEW YEAR BRiNq

To ALL OUR FRiENdS

ANd FAMiLy

Joy,

HEALTh,

PROSpERiTy

to-a&

to- aff
otti.jvently/
and ivlatives.

owt-
orriendr,

andreiatioes4

HARVEY & DAHLIA KLEIN
JODIE, AMY AND JOSH

JONAS & ANDREA
GOLDBERG
AND THEIR CHILDREN

ANd EvERyrhiNg

Good iN LiFE.

IRV & KATE LAWTON
ROBERT & ANDI LAWTON
HAROLD FINE

12.1n11 ►

ar3 mu'?

=In

nall5

to- at
ottr-fpientic,

andpetathies,

CATHY & ALAN FOSTER
& FAMILY

ALEX & HOWARD
SPINNER

Ike coming

year' Le

wilk

filled

keallk and

kappine2 and peo2 peeily

9/25

1998

4.6 Detroit Jewish News

Mtn

tail
(may/vent&
antbcelatium

^ay

Non-Invasive
Diagnosis

lerusalem — A non-
invasive method for
distinguishing between
different types of
tumors has been developed by
Professor Hadassa Degani of
the Weizmann Institute of
Science. The approach may
also help establish the progno-
sis of cancer and monitor the
effectiveness of therapy.
In a study reported in a
.recent issue of Nature Medicine,
Professor Degani and col-
leagues showed how the
method can be successfully
employed to diagnose tumors
of the breast.

Ri

MIRLE & GENE PERLSTEIN

lanDn

5759

foe

Breast tumors
react
differently to
the material.

The method consists of
injecting a contrast-enhancing
dye-like material into the
patient's bloodstream and using
magnetic resonance imaging
(MRI) to monitor the way in
which this material is taken up
and cleared out by the tumor
tissue. Because the uptake and
clearance differ for malignant
and benign tumors, such mon-
itoring makes it possible to
make a diagnosis.
An image of the tumor
shows up on a computer screen
in different colors reflecting the
distribution of the contrast
material. The color patterns for
malignant and benign growths
are strikingly different.
"We have demonstrated that
our approach works," says
Degani, "but now it needs to
be tested and evaluated in a
large-scale trial before it can be
widely applied in clinical prac-
tice.''
The Weizman Institute is
setting up the necessary trials
to test the new method, but
definitive results are not
expected for sometime.